Ochsner Health Selects DeepScribe to Bring Ambient AI to Their 4,700 Clinicians

The collaboration has seen notable results for patient satisfaction and provider adoption, with DeepScribe AI to be rolled out across the 46-hospital system

SAN FRANCISCO, July 30, 2024 /PRNewswire/ — DeepScribe, the leader in ambient AI clinical documentation, announces an enterprise-wide agreement that brings their technology to Ochsner Health, the leading nonprofit healthcare provider in the Gulf South. DeepScribe ambient AI turns each patient conversation into a complete, accurate note with real-time insights for clinicians, empowering them to be fully present with the patient while helping health systems achieve quality and value-based goals.

With 4,700 employed and affiliated physicians, Ochsner Health delivers expert care at 46 hospitals and more than 370 health and urgent care centers.

Ideal for large healthcare organizations like Ochsner Health, DeepScribe’s Large Language Model (LLM) – HealAI – is specifically trained to understand the needs and workflows of each medical specialty. Clinicians can also choose from more than 50 options to personalize their notes, their way.

Ochsner Health clinicians using DeepScribe have already experienced a positive effect on the patient experience, with 96 percent of patients stating they are likely to recommend the provider.

“Our physicians can focus entirely on the patient, knowing that documentation is being completed seamlessly in the background,” said Jason Hill, MD, Innovation Officer at Ochsner Health. “DeepScribe’s Customization Studio and deep Epic integration have allowed us to deploy ambient AI with specialty-specific workflows that accommodate physician preferences while aligning with Ochsner-specific requirements. The result is consistently high-quality notes and high clinician adoption.”

Clinicians across Ochsner Health have already expressed satisfaction with DeepScribe’s ambient AI documentation. DeepScribe customization capabilities – per specialty, workflow, and provider – give Ochsner Health the control to drive system-wide standardization while satisfying providers’ desire to produce notes to their preferences. The result is a 75% clinician adoption rate during the initial launch – and ongoing time savings.

“Before using DeepScribe, I spent at least two to three hours a day preparing for visits and then going back and editing notes based on patient conversations,” explained Dr. Terrance Wickman, an Ochsner Health nephrologist. “Now, I have been able to streamline that into three to four minutes per note. So documentation takes me about a quarter of the time.”

“I love the assessment and plan,” added Erica Doubleday, an oncology nurse practitioner at Ochsner Health. “Not only does it capture way more than I’m able to, but it writes it so succinctly.”

“We believe that the differences in every clinician’s workflow and personal preferences should be celebrated,” said Matthew Ko, DeepScribe COO and co-founder. “We have specifically designed the technology so every physician can customize it for how they work and care for patients.”

“It is inspiring to see how the Ochsner team has adopted DeepScribe across its various departments,” said Akilesh Bapu, DeepScribe CEO and co-founder. “It motivates us to continue delivering the most scalable, flexible solution to match unique system requirements and clinician workflows.”

This partnership sets the stage for further expansion of DeepScribe throughout Ochsner Health with a continued focus on co-developing ambient AI solutions that will best serve the health system’s clinical and organizational needs.

About DeepScribe
DeepScribe is the leader in ambient intelligence for healthcare, with a platform that automatically produces complete, accurate documentation and delivers real-time insights to physicians in the moment of care. Built on the world’s largest database of patient conversations, DeepScribe’s AI technology, HealAI, is trained to manage the most complex cases, with customized workflows for each medical specialty. DeepScribe has raised $60 million in funding to expand their ambient intelligence platform and bring their technology to more healthcare organizations. With a mission to bring the joy of care back to medicine, DeepScribe frees clinicians to be wholly present with patients while ambient intelligence helps them make the most of every encounter. Visit deepscribe.ai to learn more.

About Ochsner Health
Ochsner Health is the leading nonprofit healthcare provider in the Gulf South, delivering expert care at its 46 hospitals and more than 370 health and urgent care centers. For 13 consecutive years, U.S. News & World Report has recognized Ochsner as the No. 1 hospital in Louisiana. Additionally, Ochsner Children’s has been recognized as the No. 1 hospital for kids in Louisiana for three consecutive years. Ochsner inspires healthier lives and stronger communities through a combination of standard-setting expertise, quality and connection not found anywhere else in the region. In 2023, Ochsner Health cared for more than 1.5 million people from every state in the nation and 65 countries. Ochsner’s workforce includes more than 38,000 dedicated team members and over 4,700 employed and affiliated physicians.

Erin Farrell Talbot for DeepScribe
917-232-9309
erin@deepscribe.ai

View original content to download multimedia:https://www.prnewswire.com/news-releases/ochsner-health-selects-deepscribe-to-bring-ambient-ai-to-their-4-700-clinicians-302209853.html

SOURCE DeepScribe

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

2 days ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

2 days ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago